SUBSCRIBE
SUBSCRIBE
News   FDA

Genentech’s (JOBS) Psoriasis Drug Raptiva Gets FDA Warning

October 17, 2008 | 
1 min read
WASHINGTON, Oct 16 (Reuters) - U.S. health regulators have ordered strong black-box warnings for Genentech Inc's psoriasis drug, Raptiva, saying patients given the once-weekly injections are at risk for life-threatening infections.
FDA Approvals
Genentech, Inc. Food and Drug Administration (FDA)
MORE ON THIS TOPIC
halftone magazine style banner, dislike, negative rating, hand thumbs down
FDA
FDA Drops Another Cache of Heavily Redacted Rejection Letters, Promises Future ‘Real-Time’ Access
September 4, 2025
 · 
4 min read
 · 
Annalee Armstrong
Washington, D.C., USA- January 13, 2020: FDA Sign at its headquarters in Washington DC. The Food and Drug Administration (FDA or USFDA) is a federal agency of the USA.
Regulatory
‘All Wrapper, No Gift’: FDA Releases New Rare Disease Approval Framework
September 4, 2025
 · 
2 min read
 · 
Tristan Manalac
Vaccines
Prasad Signals Steeper Requirements for COVID-19 Vaccines
September 3, 2025
 · 
3 min read
 · 
Tristan Manalac
FDA
Offit Out at FDA Vaccine Advisory Committee After HHS Rebuff
September 2, 2025
 · 
3 min read
 · 
Heather McKenzie